These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28859261)

  • 1. Long-term survival following the development of heart failure in an elderly hypertensive population.
    Sahle BW; Owen AJ; Wing LMH; Beilin LJ; Krum H; Reid CM;
    Cardiovasc Ther; 2017 Dec; 35(6):. PubMed ID: 28859261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study.
    Chowdhury EK; Owen A; Ademi Z; Krum H; Johnston CI; Wing LM; Nelson MR; Reid CM;
    Am J Hypertens; 2014 Feb; 27(2):199-206. PubMed ID: 24249722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of heart failure in 6083 elderly hypertensive patients: the Second Australian National Blood Pressure Study (ANBP2).
    Sahle BW; Owen AJ; Krum H; Reid CM;
    Eur J Heart Fail; 2016 Jan; 18(1):38-45. PubMed ID: 26508441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.
    Einhorn PT; Davis BR; Massie BM; Cushman WC; Piller LB; Simpson LM; Levy D; Nwachuku CE; Black HR;
    Am Heart J; 2007 Jan; 153(1):42-53. PubMed ID: 17174636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility of angiotensin-converting enzyme inhibitor-based treatment compared with thiazide diuretic-based treatment for hypertension in elderly Australians considering diabetes as comorbidity.
    Chowdhury EK; Ademi Z; Moss JR; Wing LMH; Reid CM;
    Medicine (Baltimore); 2015 Mar; 94(9):e590. PubMed ID: 25738481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of drug therapy management and the prevalence of heart failure in a managed care population with hypertension.
    Jackson JH; Frech F; Ronen R; Mullany L; Lennert B; Jhaveri V
    J Manag Care Pharm; 2004; 10(6):513-20. PubMed ID: 15548123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.
    Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Macdonald GJ; Marley JE; Morgan TO; West MJ;
    N Engl J Med; 2003 Feb; 348(7):583-92. PubMed ID: 12584366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia.
    Wing LM; Reid CM; Ryan P; Beilin LJ; Brown MA; Jennings GL; Johnston CI; McNeil JJ; Marley JE; Morgan TO; Shaw J; Steven ID; West MJ
    Clin Exp Hypertens; 1997; 19(5-6):779-91. PubMed ID: 9247755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.
    Regitz-Zagrosek V; Lehmkuhl E
    Herz; 2005 Aug; 30(5):356-67. PubMed ID: 16132238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of depression with mortality in an elderly treated hypertensive population.
    Chowdhury EK; Berk M; Nelson MR; Wing LMH; Reid CM
    Int Psychogeriatr; 2019 Mar; 31(3):371-381. PubMed ID: 30099979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
    Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
    JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.
    Jhund PS; Macintyre K; Simpson CR; Lewsey JD; Stewart S; Redpath A; Chalmers JW; Capewell S; McMurray JJ
    Circulation; 2009 Feb; 119(4):515-23. PubMed ID: 19153268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
    Gheorghiade M; Böhm M; Greene SJ; Fonarow GC; Lewis EF; Zannad F; Solomon SD; Baschiera F; Botha J; Hua TA; Gimpelewicz CR; Jaumont X; Lesogor A; Maggioni AP;
    JAMA; 2013 Mar; 309(11):1125-35. PubMed ID: 23478743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antihypertensive therapy among patients with COPD.
    Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
    Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes.
    Kostis JB; Wilson AC; Freudenberger RS; Cosgrove NM; Pressel SL; Davis BR;
    Am J Cardiol; 2005 Jan; 95(1):29-35. PubMed ID: 15619390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult hypertension: reducing cardiovascular morbidity and mortality.
    Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.